Galapagos NV Total Liabilities

Latest as of March 2026: €119.06 Million EUR ≈ $139.19 Million USD

Galapagos NV total liabilities. Based on the latest financial reports, Galapagos NV (GXEA) has total liabilities worth €119.06 Million EUR (≈ $139.19 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Galapagos NV to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Galapagos NV (2016–2025)

Total liabilities of Galapagos NV from 2016 to 2025. This chart illustrates how Galapagos NV's total liabilities have evolved over time, based on quarterly financial data. Explore GXEA long-term investment intensity to see how much of total assets are deployed in long-term investments.

Galapagos NV Competitors by Total Liabilities

The table below lists competitors of Galapagos NV ranked by their total liabilities.

Company	Country	Total Liabilities
Skywater Technology Inc NASDAQ:SKYT	USA	$536.67 Million
Akzo Nobel India Limited NSE:AKZOINDIA	India	Rs13.44 Billion
Ningbo ZhongDa Leader Intelligent Transmission Co Ltd SHE:002896	China	CN¥649.06 Million
ShenZhen Yitoa Intelligent Control Co Ltd SHE:300131	China	CN¥1.80 Billion
Ambea AB ST:AMBEA	Sweden	Skr15.81 Billion
Trinity Capital Inc. NASDAQ:TRIN	USA	$1.54 Billion
Live Oak Bancshares, Inc. NYSE:LOB	USA	$14.72 Billion
Akr Corporindo Tbk JK:AKRA	Indonesia	Rp22.93 Trillion

Liability Composition Analysis (2016–2025)

This chart breaks down Galapagos NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see GXEA asset base.

Liquidity & Leverage Metrics

Galapagos NV Total Liabilities Ratios Explained

Galapagos NV total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	30.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.04	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Galapagos NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Galapagos NV (2016–2025)

The table below shows the annual total liabilities of Galapagos NV from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€170.65 Million ≈ $199.51 Million	-86.22%
2024-12-31	€1.24 Billion ≈ $1.45 Billion	-20.68%
2023-12-31	€1.56 Billion ≈ $1.83 Billion	-29.28%
2022-12-31	€2.21 Billion ≈ $2.58 Billion	-13.39%
2021-12-31	€2.55 Billion ≈ $2.98 Billion	-16.33%
2020-12-31	€3.05 Billion ≈ $3.56 Billion	-4.56%
2019-12-31	€3.19 Billion ≈ $3.73 Billion	+1317.53%
2018-12-31	€225.25 Million ≈ $263.34 Million	-17.88%
2017-12-31	€274.29 Million ≈ $320.68 Million	-15.51%
2016-12-31	€324.64 Million ≈ $379.53 Million	--

About Galapagos NV

F:GXEA Germany Biotechnology

Market Cap

$2.22 Billion

€1.90 Billion EUR

Market Cap Rank

#6699 Global

#991 in Germany

Share Price

€28.80

Change (1 day)

+0.70%

52-Week Range

€22.40 - €29.20

All Time High

€246.00